DaVita Cash Flow Statement
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DaVita free cash flow
In fiscal 2025, DaVita generated $1.89 billion of operating cash flow and spent $575.9 million on capital expenditures. That left free cash flow of $1.31 billion, a free-cash-flow margin of 9.6% of revenue. Free cash flow was down 10.6% from the prior year's $1.47 billion.
DaVita returned $1.31 billion to shareholders through share repurchases, equal to 100% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
DaVita cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.08B | 1.25B | 956.98M | 781.64M | 1.21B | 994.68M | 1.02B | 333.04M | 830.55M | 1.03B |
| Net Income growth (YoY) | -13.75% | +30.70% | +22.43% | -35.50% | +21.82% | -2.61% | +206.66% | -59.90% | -19.60% | +141.71% |
| Depreciation & Amortization | 708.25M | 716.40M | 736.47M | 721.13M | 667.75M | 616.63M | 600.90M | 574.80M | 544.13M | 494.94M |
| Stock-Based Compensation | 139.95M | 102.79M | 112.38M | 95.43M | 102.21M | 91.46M | 67.85M | 73.06M | 35.09M | 38.34M |
| Change in Working Capital | -102.28M | -10.13M | 167.12M | -61.67M | -162.74M | 3.76M | -154.34M | -43.63M | -148.05M | -117.42M |
| Operating Cash Flow | 1.89B | 2.02B | 2.06B | 1.56B | 1.93B | 1.98B | 2.07B | 1.77B | 1.91B | 1.97B |
| Capital Expenditures | -575.86M | -555.44M | -567.99M | -603.43M | -641.47M | -674.54M | -766.55M | -987.14M | -905.25M | -829.10M |
| Investing Cash Flow | -654.95M | -771.43M | -771.80M | -630.35M | -784.73M | -825.37M | 3.00B | -1.01B | -1.36B | -1.20B |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Share Repurchases | -1.31B | -1.39B | -272.22M | -802.23M | -1.54B | -1.46B | -2.38B | -1.16B | -802.95M | -1.10B |
| Debt Issued | 5.61B | 6.62B | 2.47B | 2.39B | 1.62B | 4.05B | 38.53B | 59.93B | 50.99B | 51.99B |
| Financing Cash Flow | -1.37B | -816.94M | -1.17B | -1.12B | -1.08B | -1.85B | -4.70B | -625.35M | -766.26M | -1.35B |
| Net Change in Cash | -122.08M | 415.19M | 125.64M | -215.97M | 53.17M | -706.93M | 369.49M | 137.29M | -217.57M | -577.25M |
| Free Cash Flow | 1.31B | 1.47B | 1.49B | 961.14M | 1.29B | 1.30B | 1.31B | 784.50M | 1.01B | 1.14B |
This table shows 10 annual periods of DaVita's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DVA's reporting calendar. What is a cash flow statement?